Case number 2017-2020
Impax Laboratories Inc. v. Lannett Holdings Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | IMPAX LABORATORIES INC. v. LANNETT HOLDINGS INC. [OPINION] [precedential] (0) |
| Apr 23, 2021 | 0 | IMPAX LABORATORIES INC. v. LANNETT HOLDINGS INC. [ERRATA] [precedential] (0) |
| Sep 21, 2018 | 66 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [551601] [JAB] [Entered: 09/21/2018 09:39 AM] (1) |
| Sep 14, 2018 | 65 | ORDER filed denying [62] petition for panel rehearing filed by Lannett Holdings Inc. and Lannett Company Inc.; denying [62] petition for en banc rehearing filed by Lannett Holdings Inc. and Lannett Company Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [549914] [SJ] [Entered: 09/14/2018 02:51 PM] (2) |
| Aug 15, 2018 | 64 | 18 paper copies of the petition for panel rehearing [62], petition for en banc rehearing [62] received from Appellants Lannett Company Inc. and Lannett Holdings Inc. [542971] [JAB] [Entered: 08/15/2018 10:57 AM] (0) |
| Aug 14, 2018 | 63 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: petition for panel rehearing Docket No. [62], petition for en banc rehearing Docket No. [62], ERROR: COI is incomplete. CORRECTION: all future filings in which a COI is included must contain the current edition of the form, which has 5 questions. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [542663] [SJ] [Entered: 08/14/2018 10:26 AM] (0) |
| Aug 13, 2018 | 62 | Petition for panel rehearing, for en banc rehearing filed by Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 08/13/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 08/15/2018 [542576] [17-2020] [Joseph Posillico] [Entered: 08/13/2018 11:58 PM] (47) |
| Jul 26, 2018 | 61 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [60] filed by Appellants Lannett Holdings Inc. and Lannett Company Inc. Petition for Rehearing due on or before 08/13/2018. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [538701] [SJ] [Entered: 07/26/2018 11:23 AM] (2) |
| Jul 23, 2018 | 60 | MOTION of Appellants Lannett Company Inc. and Lannett Holdings Inc. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 08/13/2018 [Consent: unopposed]. Service: 07/23/2018 by email. [537974] [17-2020] [Frank Carroll] [Entered: 07/23/2018 05:05 PM] (7) |
| Jul 2, 2018 | 59 | ERRATUM to the Precedential Opinion Doc No.: [58]. Service as of this date by the Clerk of Court. [533140] [JAB] [Entered: 07/02/2018 02:24 PM] (1) |
| Jun 28, 2018 | 58 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Lourie, Circuit Judge; Dyk, Circuit Judge and Taranto, Circuit Judge). [532441] [SJ] [Entered: 06/28/2018 09:54 AM] (20) |
| Apr 19, 2018 | 57 | RESPONSE of Appellees Astrazeneca AB, AstraZeneca UK Limited and Impax Laboratories Inc. to the supplemental authority [54] filed by Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 04/19/2018 by email. [515189] [17-2020] [James Hurst] [Entered: 04/19/2018 10:35 AM] (3) |
| Apr 19, 2018 | 56 | NOTICE OF DEFICIENCY: The party letter Document No. [55] filed by Appellees Astrazeneca AB, AstraZeneca UK Limited and Impax Laboratories Inc. in 17-2020 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. When filing a response to a citation of supplemental authority pursuant to FRAP 28(j), counsel must use the event "Response/Opposition to Other Document," which can be found under the event category "Response/Reply." At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [515099] [JAB] [Entered: 04/19/2018 08:18 AM] (0) |
| Apr 18, 2018 | 55 | Letter from Appellees Astrazeneca AB, AstraZeneca UK Limited and Impax Laboratories Inc. Regarding Objections to Appellants' FRAP 28(j) Letter. Service: 04/18/2018 by email. [515004] [17-2020] [James Hurst] [Entered: 04/18/2018 04:53 PM] (0) |
| Apr 16, 2018 | 54 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 04/16/2018 by email. [513614] [17-2020] [Joseph Posillico] [Entered: 04/16/2018 12:08 PM] (19) |
| Apr 16, 2018 | 53 | NOTICE OF DEFICIENCY: The party letter Document No. [52] filed by Appellants Lannett Holdings Inc. and Lannett Company Inc. in 17-2020 is submitted using the incorrect event and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency [resubmit using the event "Citation of Supplemental Authority" found under the Calendar, Letters and Notices, or Miscellaneous event categories]. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [513483] [JAB] [Entered: 04/16/2018 08:28 AM] (0) |
| Apr 13, 2018 | 52 | Letter from Appellants Lannett Company Inc. and Lannett Holdings Inc. Letter to the Court submitting cases.. Service: 04/13/2018 by email. [513465] [17-2020] [Joseph Posillico] [Entered: 04/13/2018 07:04 PM] (0) |
| Apr 5, 2018 | 51 | Submitted after ORAL ARGUMENT by Joseph F. Posillico for Lannett Holdings Inc. and Lannett Company Inc. and James F. Hurst for Astrazeneca AB, AstraZeneca UK Limited and Impax Laboratories Inc. Panel: Judge: Lourie , Judge: Dyk , Judge: Taranto. [510828] [JAB] [Entered: 04/05/2018 11:11 AM] (0) |
| Mar 14, 2018 | 50 | CORRECTED Response to oral argument order from the Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. designating James F. Hurst as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [505160] [James Hurst] [Entered: 03/14/2018 04:49 PM] (0) |
| Mar 14, 2018 | 49 | Response to oral argument order from the Appellants Lannett Company Inc. and Lannett Holdings Inc.. designating Joseph F. Posillico as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [505105] [Joseph Posillico] [Entered: 03/14/2018 03:55 PM] (0) |
| Mar 14, 2018 | 48 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [47], ERROR: Counsel for appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc. submitted a response to the oral argument order designating 12 minutes for argument and 3 minutes for rebuttal. The Oral Argument Order issued with the Notice of Calendaring states that appellees may not divide argument time. CORRECTION: Please promptly submit a corrected response. [504841] [JAB] [Entered: 03/14/2018 09:03 AM] (0) |
| Mar 13, 2018 | 47 | Response to oral argument order from the Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. designating James F. Hurst as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [504770] [James Hurst] [Entered: 03/13/2018 05:02 PM] (0) |
| Feb 21, 2018 | 46 | NOTICE OF CALENDARING. Panel: 1804J. Case scheduled Apr 05, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 03/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [499746] [JAB] [Entered: 02/21/2018 12:56 PM] (0) |
| Nov 13, 2017 | 45 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 11/13/2017 by email. [474787] [Joseph Posillico] [Entered: 11/13/2017 01:20 PM] (3) |
| Nov 2, 2017 | 44 | Notice from Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc. regarding conflicts with oral argument (Conflicts on January 8-12, 2018). Service: 11/02/2017 by email. [472671] [Marcus Sernel] [Entered: 11/02/2017 07:58 PM] (4) |
| Nov 2, 2017 | 43 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Service: 11/02/2017 by email. [472670] [Marcus Sernel] [Entered: 11/02/2017 07:55 PM] (3) |
| Nov 2, 2017 | 42 | Notice from Appellants Lannett Company Inc. and Lannett Holdings Inc. regarding conflicts with oral argument (None.). Service: 11/02/2017 by email. [472666] [Joseph Posillico] [Entered: 11/02/2017 07:25 PM] (3) |
| Nov 2, 2017 | 41 | 6 paper copies of the Corrected Confidential Joint Appendix (Vols. I-V) [37] received from Appellants Lannett Company Inc. and Lannett Holdings Inc. [472438] [CW] [Entered: 11/02/2017 12:09 PM] (0) |
| Oct 26, 2017 | 40 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [JAN, FEB, MAR], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 11/02/2017. [470738] [MJL] [Entered: 10/26/2017 10:17 AM] (0) |
| Oct 26, 2017 | 39 | Notice to counsel: The record of this case indicates that the Certificate of Compliance with Fed. Cir. R. 11(d) has not been filed. IF any portion of the record in the trial court is subject to a protective order, counsel should promptly file the Certificate of Compliance using the Cert of Compliance Modification of Protective Order (R11/17) event which is found in the Forms and Certificates category. Service as of this date by Clerk of Court. [470733] [MJL] [Entered: 10/26/2017 10:13 AM] (0) |
| Oct 25, 2017 | 35 | TENDERED from Appellants Lannett Company Inc., Lannett Holdings Inc. and Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Title: AMENDED CONFIDENTIAL JOINT APPENDIX Service: 10/25/2017 by email. [470519] [Joseph Posillico] [Entered: 10/25/2017 03:08 PM] (0) |
| Oct 25, 2017 | 36 | TENDERED from Appellants Lannett Company Inc., Lannett Holdings Inc. and Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Title: AMENDED JOINT APPENDIX. Service: 10/25/2017 by email. [470526] [Joseph Posillico] [Entered: 10/25/2017 03:19 PM] (1207) |
| Oct 25, 2017 | 37 | CORRECTED CONFIDENTIAL JOINT APPENDIX FILED for Lannett Company Inc. and Lannett Holdings Inc. [35]. Number of Pages: 1305. Service: 10/25/2017 by email. The paper copies of the confidential version of the appendix should be received by the court on or before 11/02/2017. [470727] [MJL] [Entered: 10/26/2017 10:08 AM] (0) |
| Oct 25, 2017 | 38 | CORRECTED APPENDIX FILED for Lannett Company Inc. and Lannett Holdings Inc. [36]. Number of Pages: 1207. Service: 10/25/2017 by email. Paper copies should be provided of the confidential version only. [470729] [MJL] [Entered: 10/26/2017 10:11 AM] (1207) |
| Oct 11, 2017 | 34 | NOTICE OF REJECTION: The Joint Appendix of Appellants Lannett Company Inc. and Lannett Holdings Inc. (Confidential [32], Non-Confidential [33]) is not in compliance with the rules of this court and is therefore rejected for filing. Corrected appendix due 10/25/2017. Service as of this date by Clerk of Court. [466961] [MJL] [Entered: 10/11/2017 01:27 PM] (2) |
| Oct 10, 2017 | 32 | TENDERED from Appellants Lannett Company Inc., Lannett Holdings Inc. and Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 10/10/2017 by email. [466721]. This appendix has been rejected. See Doc. No. [34]. [Joseph Posillico] [Entered: 10/10/2017 07:21 PM] (0) |
| Oct 10, 2017 | 33 | TENDERED from Appellants Lannett Company Inc., Lannett Holdings Inc. and Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Title: JOINT APPENDIX. Service: 10/10/2017 by email. [466730]. This appendix has been rejected. See Doc. No. [34]. [Joseph Posillico] [Entered: 10/10/2017 07:58 PM] (0) |
| Oct 10, 2017 | 31 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Lannett Company Inc., Lannett Holdings Inc. and Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Service: 10/10/2017 by email. [466620] [Joseph Posillico] [Entered: 10/10/2017 04:10 PM] (3) |
| Oct 6, 2017 | 30 | 6 paper copies of the Reply Brief [29] received from Appellants Lannett Company Inc. and Lannett Holdings Inc. [466078] [CW] [Entered: 10/06/2017 11:47 AM] (0) |
| Oct 3, 2017 | 29 | REPLY BRIEF FILED for Appellants Lannett Company Inc. and Lannett Holdings Inc. [28]. Number of Pages: 32. Service: 10/03/2017 by email. The paper copies of the brief should be received by the court on or before 10/12/2017. Appendix is due 10/10/2017. [465369] [MJL] [Entered: 10/04/2017 08:23 AM] (37) |
| Oct 3, 2017 | 28 | TENDERED from Appellants Lannett Company Inc. and Lannett Holdings Inc.. Title: REPLY BRIEF. Service: 10/03/2017 by email. [465351] [Joseph Posillico] [Entered: 10/03/2017 11:30 PM] (37) |
| Sep 13, 2017 | 27 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [26] filed by Appellants Lannett Holdings Inc. and Lannett Company Inc. The brief is due 10/03/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [460697] [MJL] [Entered: 09/13/2017 01:41 PM] (0) |
| Sep 13, 2017 | 26 | MOTION of Appellants Lannett Company Inc. and Lannett Holdings Inc. to extend the time to 10/03/2017 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 09/13/2017 by email. [460677] [Joseph Posillico] [Entered: 09/13/2017 01:11 PM] (6) |
| Sep 13, 2017 | 25 | Notice of Rejection to Appellants Lannett Company Inc. and Lannett Holdings Inc., the following document is REJECTED for filing: motion to extend time [24]. Reasons: see attached. Service: 09/13/2017 by clerk. [460560] [MJL] [Entered: 09/13/2017 08:27 AM] (1) |
| Sep 12, 2017 | 24 | MOTION of Appellants Lannett Company Inc. and Lannett Holdings Inc. to extend time until 10/03/2017 to file (Extension of Time to File Responsive Briefing). [Consent: unopposed]. Service: 09/12/2017 by email. [460521] [Joseph Posillico] [Entered: 09/12/2017 05:11 PM] (5) |
| Sep 8, 2017 | 23 | 6 paper copies of the Opening Response Brief [22] received from Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc. [459673] [CW] [Entered: 09/08/2017 11:05 AM] (0) |
| Sep 5, 2017 | 22 | BRIEF FILED for Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc. [21]. Number of Pages: 76. Service: 09/05/2017 by email. The paper copies of the brief should be received by the court on or before 09/13/2017. Appellants' reply brief is due 09/19/2017. [459042] [MJL] [Entered: 09/06/2017 03:34 PM] (87) |
| Sep 5, 2017 | 21 | TENDERED from Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Title: RESPONSE BRIEF. Service: 09/05/2017 by email. [458783] [Marcus Sernel] [Entered: 09/05/2017 11:17 PM] (87) |
| Jul 31, 2017 | 20 | 6 paper copies of the Corrected Opening Brief [19] received from Appellants Lannett Company Inc. and Lannett Holdings Inc. [450555] [MJL] [Entered: 08/01/2017 09:21 AM] (0) |
| Jul 26, 2017 | 19 | CORRECTED BRIEF FILED for Appellants Lannett Company Inc. and Lannett Holdings Inc. [18]. Number of Pages: 65. Service: 07/26/2017 by email. The paper copies of the brief should be received by the court on or before 08/03/2017. [449589] [MJL] [Entered: 07/27/2017 08:50 AM] (95) |
| Jul 26, 2017 | 18 | TENDERED from Appellants Lannett Company Inc. and Lannett Holdings Inc.. Title: CORRECTED OPENING BRIEF. Service: 07/26/2017 by email. [449561] [Joseph Posillico] [Entered: 07/26/2017 09:06 PM] (95) |
| Jul 26, 2017 | 17 | Notice of Correction to the Brief Doc No. [13] for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 07/26/2017 by email. [449555] [Joseph Posillico] [Entered: 07/26/2017 08:48 PM] (4) |
| Jul 24, 2017 | 16 | **TEXT ONLY** ORDER granting motion to extend time to file appellees' response brief [15] filed by Appellees Astrazeneca AB, AstraZeneca UK Limited, and Impax Laboratories Inc. The brief is due 09/05/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [448818] [MJL] [Entered: 07/24/2017 04:26 PM] (0) |
| Jul 24, 2017 | 15 | MOTION of Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc. to extend the time to 09/05/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/24/2017 by email. [448813] [Marcus Sernel] [Entered: 07/24/2017 04:20 PM] (7) |
| Jul 12, 2017 | 14 | NOTICE OF REJECTION: The Brief for Defendants-Appellants Lannett Holdings, Inc. and Lannett Company Inc. [13] is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 07/26/2017. Appellees' brief is due 08/21/2017. Service as of this date by Clerk of Court. [445778] [MJL] [Entered: 07/12/2017 08:36 AM] (2) |
| Jul 11, 2017 | 13 | TENDERED from Appellants Lannett Company Inc. and Lannett Holdings Inc.. Title: OPENING BRIEF. Service: 07/11/2017 by email. [445768]. This brief has been rejected. See Doc. No. [14]. [Joseph Posillico] [Entered: 07/11/2017 11:40 PM] (0) |
| Jun 6, 2017 | 12 | Amended Entry of appearance for Michael W. Glynn as of counsel for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 06/06/2017 by email. [436813] [Michael Glynn] [Entered: 06/06/2017 03:33 PM] (2) |
| May 26, 2017 | 11 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The contact information on the entry of appearance for Michael W. Glynn [4] does not match the information in the attorney's user account. CORRECTION: Please update as needed with the PACER Service Center to ensure the ocntact information on the entry of appearance and in the user account matches. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [434654] [CMP] [Entered: 05/26/2017 04:44 PM] (0) |
| May 26, 2017 | 10 | Entry of appearance for Frank T. Carroll as of counsel for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 05/26/2017 by email. [434595] [Frank Carroll] [Entered: 05/26/2017 03:21 PM] (2) |
| May 26, 2017 | 9 | Certificate of Interest for the Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 05/26/2017 by email. [434583] [Joseph Posillico] [Entered: 05/26/2017 03:09 PM] (2) |
| May 26, 2017 | 8 | Docketing Statement for the Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 05/26/2017 by email. [434581] [Joseph Posillico] [Entered: 05/26/2017 03:08 PM] (5) |
| May 26, 2017 | 7 | Entry of appearance for Joseph F. Posillico as principal counsel for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 05/26/2017 by email. [434579] [Joseph Posillico] [Entered: 05/26/2017 03:07 PM] (2) |
| May 26, 2017 | 6 | Certificate of Interest for the Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Service: 05/26/2017 by US mail, email. [434564] [Marcus Sernel] [Entered: 05/26/2017 02:50 PM] (2) |
| May 26, 2017 | 5 | Docketing Statement for the Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Service: 05/26/2017 by US mail, email. [434561] [Marcus Sernel] [Entered: 05/26/2017 02:49 PM] (3) |
| May 26, 2017 | 4 | Entry of appearance for Michael W. Glynn as of counsel for Appellants Lannett Company Inc. and Lannett Holdings Inc.. Service: 05/26/2017 by email. [434559] [Michael Glynn] [Entered: 05/26/2017 02:49 PM] (2) |
| May 26, 2017 | 3 | Entry of appearance for Marcus E. Sernel as of counsel for Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Service: 05/26/2017 by US mail, email. [434557] [Marcus Sernel] [Entered: 05/26/2017 02:48 PM] (2) |
| May 26, 2017 | 2 | Entry of appearance for James F. Hurst as principal counsel for Appellees AstraZeneca UK Limited, Astrazeneca AB and Impax Laboratories Inc.. Service: 05/26/2017 by US mail, email. [434552] [Marcus Sernel] [Entered: 05/26/2017 02:46 PM] (2) |
| May 12, 2017 | 1 | Appeal docketed. Received: 05/12/2017. [431073]Entry of Appearance due 05/26/2017. Certificate of Interest due 05/26/2017. Docketing Statement due 05/26/2017. Appellants' brief due 07/11/2017. [MJL] [Entered: 05/12/2017 03:03 PM] (32) |
